+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Adenylate cyclase activity of synaptic membranes from rat striatum. Inhibition by muscarinic receptor agonists



Adenylate cyclase activity of synaptic membranes from rat striatum. Inhibition by muscarinic receptor agonists



Molecular Pharmacology 23(2): 393-398



Acetylcholine inhibits, by 30-40%, the basal adenylate cyclase activity of purified synaptic plasma membranes prepared from rat striatum (EC50 = 3 microM). Cholinergic receptor agonists inhibit this cyclase activity with the following rank order of potency: oxtremorine greater than acetylcholine greater than arecoline greater than methacholine greater than or equal to muscarine greater than or equal to carbachol greater than bethanechol. Nicotine fails to inhibit the cyclase, and d-tubocurarine fails to inhibit the action of cholinergic drugs. In contrast, atropine and scopolamine antagonize the effect of acetylcholine. The enzyme inhibition elicited by acetylcholine requires the presence of GTP, and disappears after intrastriatal injection of kainic acid. From these results, we infer that striatal adenylate cyclase can be modulated by muscarinic receptors.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 004677758

Download citation: RISBibTeXText

PMID: 6188035


Related references

Comparison of muscarinic receptor mediated inhibition of adenylate cyclase activity in the corpus striatum and heart. FASEB Journal 3(4): A1285, 1989

The muscarinic receptor adenylate cyclase complex of rat striatum: desensitization following chronic inhibition of acetylcholinesterase activity. Journal of Neurochemistry 42(5): 1439-1443, 1984

Muscarinic acetylcholine receptors linked to the inhibition of adenylate cyclase activity in membranes from the rat striatum and myocardium can be distinguished on the basis of agonist efficacy. Molecular Pharmacology 34(6): 769-778, 1988

A receptor reserve for muscarinic inhibition of adenylate cyclase activity in rat striatal membranes. British Journal Of Pharmacologyppl: 79p, 1987

Muscarinic receptor agonists inhibit adenylate cyclase of membranes from rat cerebellar granule cells in primary culture. Federation Proceedings 45(3): 661, 1986

Correlation between the binding parameters of muscarinic agonists and their inhibition of adenylate cyclase activity. Advances in Experimental Medicine and Biology 236: 265-276, 1988

Muscarinic receptor agonists inhibit cardiac adenylate cyclase activity in the presence of gdp beta s or gdp. FASEB Journal 4(7): A1985, 1990

Effects of muscarinic cholinergic receptor agonists on beta adrenergic and histamine h 2 receptor stimulated adenylate cyclase activity in guinea pig myo cardium. Clinical Research 30(4): 816A, 1982

Regulation of adenylate cyclase activity by bradykinin in membranes of neuroblastoma X glioma hybrid cells. Bradykinin inhibition of adenylate cyclase in NG 108-15 as a receptor controlled process. Comunicaciones Biologicas 11(4): 307-319, 1993

Muscarinic cholinergic receptor-mediated attenuation of adenylate cyclase activity in rat heart membranes. Journal of Cyclic Nucleotide and Protein Phosphorylation Research 10(2): 197-210, 1985

D 2 dopamine receptor mediated inhibition of adenylate cyclase activity in rat striatum. Society for Neuroscience Abstracts 10(1): 238, 1984

Differential ontogeny of functional dopamine and muscarinic receptors mediating presynaptic inhibition of neurotransmitter release and postsynaptic regulation of adenylate cyclase activity in rat striatum. Developmental Brain Research 66(1): 91-96, 1992

Inhibition of forskolin-stimulated adenylate cyclase activity by 5-HT receptor agonists. European Journal of Pharmacology 119(3): 231-234, 1985

D2 dopamine receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in rat striatum. Neuroscience Letters 59(2): 177-182, 1985

Muscarinic stimulation of adenylate cyclase activity of rat olfactory bulb. II. Characterization of the antagonist sensitivity and comparison with muscarinic inhibitions of the enzyme in striatum and heart. Journal of Pharmacology and Experimental Therapeutics 259(2): 680-686, 1991